LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

Fujiwara, K, Harter, P, Leary, A, Perol, D, Pignata, S, González-Martín, A, Petru, E, van Nieuwenhuysen, E, Colombo, N, Mäenpää, J, Selle, F, de Gregorio, N, Lorusso, D, Guerra Alia, E M, Lefeuvre-Ple
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz446.009
Date:
November, 2019
File:
PDF, 109 KB
2019
Conversion to is in progress
Conversion to is failed